Biotech had a solid week last week as the overall market broke a two week losing streak.
Gilead’s major acquisition this morning of Kite Pharma should get the sector off to a positive start this week.
All the other notable news, events and analyst ratings from across the sector are below. We also revisit Neos Therapeutics before its upcoming FDA decision date.
